Experiment 67085

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismPopulus tremuloides (SALICACEAE)
CitationRYAN,EA: IMES,S: WALLCE,C: JONES,S:. (2000). HERBAL TEA IN THE TREATMENT OF DIABETES MELLITUS.. 23(5)
Amount utilized
Compound isolated
DiseaseRANDOMIZED, PLACEBO-CONTROLLED, SINGLE-BLIND STUDY INVOLVING FORTY VOLUNTEERS WITH TYPE 2 DIABETES. AFTER A 1 MONTH "RUN-IN" PERIOD, SUBJECTS DRANK 250 ML/D OF EITHER HERBAL TEA OR A PLACEBO TEA FOR 10 DAYS, AND WERE FOLLOWED UP FOR A FURTHER 4 WKS. IN MEAN BLOOD GLUCOSE LEVELS BASED ON 4 CAPILLARY GLUCOSE READINGS DAILY. SECONDARY END POINTS INCLUDED CHANGES IN HBA-IC, FRUCTOSAMINE AND RESPONSE TO A MEAL CHALLENGE USING ENSURE. THE RESPONDER ANALYSIS SHOWED NO BENEFIT FROM THE HERBAL FRUCTOSAMINE LEVELS BEFORE AND AFTER TEA THERAPY DECREASED SIGNIFICANTLY IN BOTH STUDY GROUPS. MEAN HBA-IC LEVELS AND INCREMENTAL AREAS UNDER THE GLUCOSE CURVE(AUC) IN THE MEAL CHALLENGE DID NOT CHANGE IN EITHER STUDY GROUP. THESE DATA WERE REANALYSED IN HYPERGLYCEMIC SUBJECTS WITH HBA-IC LEVELS GREATER THAN 120% OF NORMAL. THE RESPONDER ANALYSIS AND HBA-IC LEVELS DID NOT CHANGE IN EITHER GROUP. MEAN( AND STANDARD DEVIATION) FRUCTOSAMINE LEVELS, BEFORE AND AFTER TEA THERAPY, WERE SIGNIFICANTLY LOWER IN THE HERBAL TEA GROUP THAN IN THE PLACEBO TEA GROUP(361[98] VERSUS 338[100] MICROMOL/L, P<0.01 COMPARED WITH 338 [60] VERSUS 323 [49] MICROMOL, P=0.08).
Dose amount250.0 ML
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitML
Dose expressionDOSE
ExtractINFUSION
GenderGIVEN TO BOTH SEXES